DrugPatentWatch Database Preview
Hong Kong Company Profile
What is the competitive landscape for HONG KONG, and what generic and branded alternatives to HONG KONG drugs are available?
Drugs and US Patents for Hong Kong
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hong Kong | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 206190-001 | Nov 9, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Hong Kong | TOPOTECAN HYDROCHLORIDE | topotecan hydrochloride | INJECTABLE;INJECTION | 201166-001 | Aug 8, 2012 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.